BAM
ACHL

Brave Asset Management’s Achilles Therapeutics ACHL Stock Holding History

Brave Asset Management’s Portfolio ACHL Stock Details ACHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,000
Closed -$14.5K – 184
2025
Q1 		$14.5K Hold
10,000
– – ﹤0.01% 159
2024
Q4 		$11.4K Hold
10,000
– – ﹤0.01% 163
2024
Q3 		$10.2K Hold
10,000
– – ﹤0.01% 166
2024
Q2 		$8.15K Hold
10,000
– – ﹤0.01% 159
2024
Q1 		$12.5K Buy
+10,000
New +$10.8K ﹤0.01% 165

Other funds holding ACHL

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return